patient management

Analysis of the Use of Duloxetine in the High-dose Range (90 to 120 mg) in the Psychiatric Clinic for the Treatment of Patients With Major Depressive Disorder

Analysis of the Use of Duloxetine in the High-dose Range (90 to 120 mg) in the Psychiatric Clinic for the Treatment of Patients With Major Depressive Disorder

Duloxetine Efficacy in High Doses Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor, has been widely studied for its effectiveness […]

Analysis of the Use of Duloxetine in the High-dose Range (90 to 120 mg) in the Psychiatric Clinic for the Treatment of Patients With Major Depressive Disorder Read Post »

Correction to “Interpreting the Hospital Anxiety and Depression Scale (HADS) for individuals with traumatic brain injury: Clinical correlates and empirical severity cutoffs” by Fox et al. (2026)

Study Overview This study, conducted by Fox et al. (2026), addresses the significance of the Hospital Anxiety and Depression Scale

Correction to “Interpreting the Hospital Anxiety and Depression Scale (HADS) for individuals with traumatic brain injury: Clinical correlates and empirical severity cutoffs” by Fox et al. (2026) Read Post »

Case Report: Diffuse large B-cell lymphoma presenting predominantly with spinal cord involvement: a series of three cases confirmed by abdominopelvic lymph node biopsy

Study Overview This study investigates the clinical presentation and diagnostic pathways of diffuse large B-cell lymphoma (DLBCL), specifically focusing on

Case Report: Diffuse large B-cell lymphoma presenting predominantly with spinal cord involvement: a series of three cases confirmed by abdominopelvic lymph node biopsy Read Post »

Scroll to Top